Interestingly, mGlu3 and mGlu5 receptors appeared to be highly expressed by a subgroup of GBM characterized by the expression of established markers of glutamatergic and GABAergic neurotransmission, denominated “NT-type” GBM. Here, GRM3 is linked to glioblastoma.